Near infrared diagnostic method and instrument

• US 5,197,470 A
• Filed: 07/16/1990
• Issued: 03/30/1993
• Est. Priority Date: 07/16/1990
• Status: Expired due to Term

• Current Assignee: Clinical Diagnostic Systems Inc.
• Original Assignee: Eastman Kodak Company
• Inventors: Liu, Hsue-Yang, Helfer, Jeffrey L., Switalski, Steven C.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): PONTIUS, KEVIN LANE
• Application Number:
  US07/568,452
• Time in Patent Office: 988 Days
• Field of Search: 128/664, 128/665, 128/634, 128/633, 606/2-19
• US Class Current: 600/342
• CPC Class Codes: A61B 18/245 for removing obstructions in blood vessels or calculi
• CPC Class Codes: A61B 2017/00061 spectrum
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence

Abstract

There are disclosed an instrument and method for using near IR to discriminate between healthy and diseased tissue, using, e.g., a catheter and a spectrophotometer. Near IR is passed at certain wavelengths to suspected tissue, and reflected light is analyzed to determine the absorbance, and preferably the second derivative thereof. From identification of the absorption spectra of known diseased and known healthy tissue, a relation has been established to determine the following correlation equation for determining the predictive value of y:

y=Co+C.sub.1 A(λ.sub.1)+C.sub.2 A(λ.sub.2)

wherein A(λ₁)+A(λ₂) are the second derivatives for the absorbance at the two selected wavelengths. For blood cholesterol esters and plaque, λ₁ is preferably 1714.5 and λ₂ is preferably 1678.5 nm. Solving for the coefficients Co, C₁ and C₂, it has been shown that values of y less than -8.0 represent diseased tissue, which should be treated. Ablation laser treatment is described as one mode of treatment.

Claims

1. An instrument for detecting diseased portions of body tissue, said instrument comprising

a) means for illuminating portions of said body tissue with light energy of predetermined wavelengths selected from the range of between about 1000 and 2500 nm, said predetermined wavelengths being effective to be selectively absorbed by a preselected component of said tissue,

b) means for collecting the light at said predetermined wavelengths that is not absorbed by said tissue portions,

c) means for determining from said collected light the amounts of absorbance of said light by illuminated body tissue, and

d) discriminating means for discriminating one illuminated tissue component from another illuminated tissue component at said wavelengths,

said discriminating means comprising i) means for converting said absorbance amounts into first or second derivative values, ii) storage means for storing a disease index equation, iii) means for solving this equation using said first or second derivative values to produce a disease index value, and iv) comparing means for comparing said disease index value against a threshold value for diseased and healthy conditions of said tissues,

whereby certain illuminated portions of the body tissue are identified and located as being diseased.

3. An instrument as defined in claim 1 or 2 and further including

e) means for treating only the identified and located tissue portions.

4. An instrument as defined in claim 1 or 2 wherein said illuminating means include light-energy generating means for generating said predetermined wavelengths, and at least one optical fiber for transmitting said wavelengths.

5. An instrument as defined in claim 1 or 2 wherein said illuminating means selectively illuminate at a plurality of wavelengths selectively absorbed by disease components of choice of said tissue, and said discriminating means discriminates diseased tissue from healthy tissue.

6. An instrument as defined in claim 5 wherein said wavelengths are selectively absorbed by cholesterol esters and said body tissues are cardiovascular tissues.

7. An instrument as defined in claim 6 wherein said wavelengths are selected from between about 1660 nm and about 1740 nm.

2. An instrument for detecting diseased portions of body tissue, said instrument comprising

a) means for illuminating portions of said body tissue with light energy of predetermined wavelengths selected from the range of between about 1000 and 2500 nm, said predetermined wavelengths being effective to be selectively absorbed by a preselected component of said tissue,

b) means for collecting the light at said predetermined wavelengths that is not absorbed by said tissue portions,

c) means for determining from said collected light the amounts of absorbance of said light by illuminated body tissue, and

d) discriminating means for discriminating one illuminated tissue component from another illuminated tissue component at said wavelengths, said discriminating means i) using the equation

8. A surgical instrument suitable for atherosclerosis treatment, comprising a catheter having

a distal end constructed to penetrate a blood vessel,

a proximal end constructed to remain outside the blood vessel,

and a body portion connecting said ends,

said ends and body portion including at least one optical fiber capable of delivering from one end, illumination light of desired wavelengths,

said distal end further including optical means for transmitting and receiving light energy from said fibers to a blood vessel, and from the illuminated blood vessel to said fibers, respectively;

said proximal end further including a) means for generating light energy at predetermined wavelengths between about 1660 nm and about 1740 nm, b) means for delivering said generated energy to said at least one fiber, c) means for detecting the amount of such generated energy that is not absorbed by illuminated tissue in a blood vessel, and d) means for discriminating illuminated healthy tissue from illuminated diseased tissue at said wavelengths,

said discriminating means comprising i) means for converting said absorbance amounts into first or second derivative values, ii) storage means for storing a disease index equation, iii) means for solving this equation using said first or second derivative values, to produce a disease index value and iv) comparing means for comparing said disease index value against a threshold value for diseased and healthy conditions of said tissues.

said instrument further including treating means for selectively treating only the illuminated diseased tissue as determined by said discriminating means.

9. An instrument as defined in claim 8, wherein said predetermined wavelengths generated by said light-energy generating means comprise wavelengths that are absorbed by at least some of the components of deposits that are not present in healthy blood vessel tissue.

10. An instrument as defined in claim 8, wherein said predetermined wavelengths are 1678±

20 nm and 1714±

20 nm.

11. An instrument as defined in claim 8, wherein said treating means comprise an ablating laser and switching means operatively connecting said ablating laser to said at least one fiber only when said fiber is illuminating diseased tissue as determined by said discriminating means.

12. A method of detecting certain tissue in body tissue, comprising the steps of

a) illuminating portions of said body tissue with light energy of predetermined wavelengths selected from the range of between about 1000 and about 2500 nm, said predetermined wavelengths being effective to be selectively absorbed by a preselected component of said tissue,

b) collecting the light at said predetermined wavelengths that is not absorbed from said tissue portions,

c) examining the amounts of absorbance of said light as determined from the collected amounts not absorbed by said illuminated body tissue, and

d) discriminating one illuminated tissue component from an other illuminated tissue component at said wavelengths, by i) converting said absorbance amounts into second derivative values, ii) solving a disease index equation using said second derivative values to produce a solved disease index value, and iii) comparing said solved disease index value against a threshold value for diseased conditions of said tissues, whereby certain illuminated portions of body tissue are identified and located.

13. A method of treating diseased but not healthy tissue in a body vessel, comprising the steps of

i) detecting which portions are diseased and which are healthy by the steps of claim 12 and

ii) treating only the diseased portions.

14. A method as defined in claim 13 wherein said treating step ii) comprises exposing the diseased portions to laser light at a dosage that is proportional to the certainty determined by said detecting step i) that said exposed portions are diseased.

15. A method as defined in claim 12 wherein said step a) comprises the steps of illuminating at wavelengths selectively absorbed by preselected disease components of said tissue, and said step d) discriminates diseased tissue from healthy tissue.

16. A method as defined in claim 15 wherein said wavelengths are selectively absorbed by cholesterol esters and said body tissues are cardiovascular tissues.

17. A method as defined in claim 16 wherein said wavelengths are selected from between 1660 nm and about 1740 nm.

18. A method as defined in claim 12 wherein said step a) comprises illuminating said body tissue at two predetermined wavelengths λ

₁ and λ

₂ within said 1000-2500 μ

m range,

and said step d) comprises calculating y from the equation;

space="preserve" listing-type="equation">y=Co+C.sub.1 A(λ

.sub.1)+C.sub.2 A(λ

.sub.2)

wherein A(λ

₁)+A(λ

₂) are the absorbances or the first or second derivatives of the absorbances of said tissue at said two predetermined wavelengths, and Co, C₁ and C₂ are predetermined constants, and comparing the calculated y value against a predetermined threshold value.

19. A method as defined in claim 18 wherein said equation is

20. A surgical instrument suitable for atherosclerosis treatment, comprising a catheter having

a distal end constructed to penetrate a blood vessel,

a proximal end constructed to remain outside the blood vessel,

and a body portion connecting said ends,

said ends and body portion including at least one optical fiber capable of delivering from one end, illumination light of desired wavelengths,

said distal end further including optical means for transmitting and receiving light energy from said fibers to a blood vessel, and from the illuminated blood vessel to said fibers, respectively;

said proximal end further including a) means for generating light energy at predetermined wavelengths between about 1660 nm and about 1740 nm, b) means for delivering said generated energy to said at least one fiber, c) means for detecting the amount of such generated energy that is not absorbed by illuminated tissue in a blood vessel, and d) means for discriminating illuminated healthy tissue from illuminated diseased tissue at said wavelengths, using the equation

space="preserve" listing-type="equation">y=Co+C.sub.1 A(λ

.sub.1)+C.sub.2 A(λ

.sub.2)+. . . C.sub.n A(λ

.sub.n)

wherein A(λ

₁), A(λ

₂) and A(λ

_n) are the absorbances or the first or second derivatives of the absorbances of said tissue at n predetermined wavelengths, and Co, C₁, C₂ and C_n are predetermined constants, said discriminating means being effective to compare the calculated y value against a predetermined threshold value,

said instrument further including treating means for selectively treating only the illuminated diseased tissue as determined by said discriminating means.